|
"Current Protocols in Nucleic Acid Chemistry", 2000, JOHN WILEY & SONS, INC., article "Laboratory Stock Solutions and Equipment"
|
|
A. REISCH ET AL.: "Charge-controlled nanoprecipitation as a modular approach to ultrasmall polymer nanocarriers: making bright and stable nanoparticles", ACS NANO, vol. 9, 2015, pages 5104, XP055573800, DOI: 10.1021/acsnano.5b00214
|
|
A. REISCH ET AL.: "Collective fluorescence switching of counterion-assembled dyes in polymer nanoparticles", NATUR. COMMUN., vol. 5, 2014, pages 4089
|
|
A. REISCHA. RUNSERY. ARNTZY. MELYA. S. KLYMCHENKO, CS NANO, vol. 9, no. 5, 2015, pages 104 - 5116
|
|
ACHARYA ET AL., ADV DRUG DELIV REV, vol. 63, 2011, pages 170 - 83
|
|
ALYAUTDIN ET AL., PHARMACEUTICAL RESEARCH, vol. 14, no. 3, 1997, pages 325 - 328
|
|
B. SEMETEL. BOOYSENY. LEMMERL. KALOMBOL. KATATAJ. VERSCHOORH. S. SWAI: "In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems", NANOMEDICINE: NBM, vol. 6, 2010, pages 662 - 671, XP027354340
|
|
C. FONSECA ET AL.: "Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity", J. CONTROLLED RELEASE, vol. 83, 2002, pages 273 - 286, XP004383637, DOI: 10.1016/S0168-3659(02)00212-2
|
|
C. I. C. CRUCHOM. T. BARROS, MATER. SCI. ENG. C, vol. 80, 2017, pages 771 - 784
|
|
CAI ET AL., AM J TRANSL RES, vol. 8, no. 2, 2016, pages 749 - 764
|
|
CALVO ET AL., EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 15, 2002, pages 1317 - 1326
|
|
CARINA ET AL., MATERIALS SCIENCE AND ENGINEERING C, vol. 80, 2017, pages 771 - 784
|
|
CUN ET AL., EUR J PHARM BIOPHARM, vol. 77, 2011, pages 26 - 35
|
|
DANHIER ET AL., J CONTROL. RELEASE., vol. 161, 2012, pages 505 - 22
|
|
DEBNATH ET AL., RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY, vol. 4, no. 4, 2011, pages 492 - 495
|
|
FERGUSON ET AL., BIOPHYSICAL JOURNAL, vol. 95, no. 4, 2008, pages 1945 - 55
|
|
G. TOSIF. RIVASIF. GANDOLFIL. COSTANTINOM. A. VANDELLIF. FORMI, BIOMATERIALS, vol. 26, 2005, pages 4189 - 4195
|
|
H. K. WILSONS. G. CANFIELDM. K. HJORTNESSS. P. PALECEKE. V. SHUSTA, FLUIDS BARRIERS CNS, vol. 12, 2015, pages 13
|
|
J. A. LOUREIRO ET AL.: "Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer-s disease treatment", COLLOIDS SURFB BIOINTERFACES, vol. 145, 2016, pages 8, XP029639988, DOI: 10.1016/j.colsurfb.2016.04.041
|
|
J. CHENG ET AL.: "R. Langer) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery", BIOMATERIALS, vol. 28, 2007, pages 869
|
|
J. SUKSIRIWORAPONGV. TARESCOD. P. IVANOVI. D. STYLIARIK. SAKCHAISRIV. B. JUNYAPRASERTM. C. GARNETT, COLLOIDS SURF. BIOINTERFACES, vol. 167, 2018, pages 115 - 125
|
|
J. YANG ET AL.: "Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer", J. MATER. CHEM., vol. 17, 2007, pages 2695, XP055449425, DOI: 10.1039/b702538f
|
|
JIANG ET AL., JBIOMEDMATER RES B APPL BIOMATER, vol. 97, no. 2, May 2011 (2011-05-01), pages 355 - 63
|
|
KAKSONENROUX, NATURE REVIEWS MOLECULAR CELL BIOLOGY, vol. 19, 2018, pages 313 - 326
|
|
KIMKIM, POLYMER, vol. 52, 2011, pages 3325 - 3336
|
|
KIRCHHAUSEN ET AL., COLD SPRING HARB PERSPECT BIOL, vol. 6, no. 5, 2014, pages a016725
|
|
KREUTER, ADVANCED DRUG DELIVERY REVIEWS, vol. 47, 2001, pages 65 - 81
|
|
KREUTER, CURRENT MEDICINAL CHEMISTRY-CENTRAL NERVOUS SYSTEM AGENTS, vol. 2, 2002, pages 241 - 249
|
|
KREUTER, JOURNAL OF ANATOMY, vol. 189, 1996, pages 503 - 505
|
|
LABBAF ET AL., MACROMOL. RAPID COMMUN., vol. 35, 2014, pages 618 - 623
|
|
LI ET AL., TRENDS IN PHARMACOLOGICAL SCIENCES, vol. 23, no. 5, 2002, pages 206 - 209
|
|
M. A. VAKILINEZHADA. AMINIT. DARAS. ALIPOUR, COLLOIDS SURFBIOINTERFACES, vol. 184, 2019, pages 110515 - 110522
|
|
M. CHORNY ET AL.: "Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug, recovery and release kinetics", J. CONTROLLED RELEASE, vol. 83, 2002, pages 389, XP004387598, DOI: 10.1016/S0168-3659(02)00211-0
|
|
M. COMES FRANCHINI ET AL.: "Design and synthesis of novel 3,4-substituted pyrazoles for nanomedicine applications against malignant gliomas", EUR. J. MED. CHEM., vol. 45, 2010, pages 2024
|
|
M. E. KEEGAN ET AL.: "Biodegradable microspheres with enhanced capacity for covalently bound surface ligands", MACROMOLECULES, vol. 37, 2004, pages 9779, XP002498493, DOI: 10.1021/MA049470U
|
|
M. Y. BAIS. Z. LIU, COLLOIDS SURF. BIOINTERFACES, vol. 117, 2014, pages 346 - 353
|
|
MAKADIA ET AL., POLYMERS (BASEL), vol. 3, no. 3, 1 September 2011 (2011-09-01), pages 1377 - 1397
|
|
N. ZHANG ET AL.: "PLGA Nanoparticle-Peptide conjugate effectively targets intercellular cell-adhesion molecule-1", BIOCONJUGATE CHEM, vol. 19, 2008, pages 145, XP055176937, DOI: 10.1021/bc700227z
|
|
O. C. FAROKHZADJ. CHENGB. A. TEPLYI. SHERIFIS. JONP. W. KANTOFFJ. P. RICHIER. LANGER: "Robert Langer) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo", PNAS, vol. 103, 2006, pages 6315
|
|
OSSWALD ET AL., ANN BIOMED ENG, vol. 43, no. 11, November 2015 (2015-11-01), pages 2609 - 17
|
|
P. KESHARWANIA. JAINA. JAINA. K. JAINN. K. GARGR. K. TEKADET. R. R. SINGHA. K. IYER, RSC ADV, vol. 6, no. 8, 2016, pages 9040 - 89050
|
|
P. ZHAIX. B. CHEND. J. SCHREYER, MATER. SCI. ENG. C, vol. 56, 2015, pages 251 - 259
|
|
PEDROSO-SANTANAFLEITAS-SALAZAR, POLYMER INTERNATIONAL, vol. 69, no. 5, 2020, pages 443 - 447
|
|
RAMGE ET AL., EUROPEAN JOURNAL OF NEUROSCIENCE, vol. 12, 2000, pages 1931 - 1940
|
|
ROUSSELLE ET AL., MOLECULAR PHARMACOLOGY, vol. 57, 2000, pages 679 - 686
|
|
RUOZI ET AL., INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 526, 2017, pages 413 - 4240
|
|
S. GURDAGJ. KHANDARES. STAPELSL. H. MATHERLYR. M. KANNAN, BIOCONJUGATE CHEM, vol. 17, 2006, pages 275 - 283
|
|
SAH ET AL., INT J NANOMEDICINE, vol. 8, 2013, pages 747 - 765
|
|
SCHROEDER ET AL., JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 87, no. 11, 1998, pages 1305 - 1307
|
|
SCHROEDER ET AL., PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY, vol. 23, 1999, pages 941 - 949
|
|
SREEKUMAR ET AL., NATURE SCIENTIFIC REPORTS, vol. 8, 2018, pages 4695
|
|
T. BETANCOURT ET AL.: "PEGylation strategies for active targeting of PLA/PLGA nanoparticles", J. BIOMED. MATER. RESEARCH, 2008, pages 263
|
|
T. BETANCOURTJ. D. BYRNEN. SUNARYOS. W. CROWDERM. KADAPAKKAMS. PATELS. CASCIATOL. BRANNON-PEPPAS, J. BIOMED. MATER. RES., vol. 91A, 2008, pages 263 - 276
|
|
VASIR ET AL., ADV DRUG DELIV REV, vol. 59, no. 8, 10 August 2007 (2007-08-10), pages 718 - 28
|
|
WANG ET AL., FRONTIERS IN CHEMISTRY, vol. 7, 2019, pages 1 - 9
|
|
WANG ET AL., MOLECULAR THERAPY, vol. 3, no. 5, 2001, pages 658 - 664
|
|
WU ET AL., J BIOMATER SCI POLYM ED, vol. 12, no. 1, 2001, pages 21 - 34
|
|
X. NIU ET AL.: "Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles", DRUG DEV. IND PHARM., vol. 35, 2009, pages 1375
|
|
ZHANG ET AL., POLYM. SCI. SER. B, vol. 58, 2016, pages 720 - 729
|